angiotensin ii has been researched along with Sclerosis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hara, T; Hitomi, H; Ihara, G; Ito, S; Kiyomoto, H; Kobori, H; Kohno, M; Mori, T; Nagai, Y; Nakano, D; Nishiyama, A; Ohashi, N; Pelisch, N | 1 |
| Caulfield, MT; McDonald, TO; O'Brien, KD; Olin-Lewis, K; Otto, CM; Probstfield, JL; Shavelle, DM | 1 |
| Fakhry, I; Gehr, TW; Ghosh, S; Haas, M; Quigg, RJ; Schoolwerth, AC; Sica, D | 1 |
| Burcklé, C; Nguyen, G; Sraer, JD | 1 |
| Boffa, JJ; Chatziantoniou, C; Dussaule, JC; Fakhouri, F; Flamant, M; Tharaux, PL | 1 |
| Ronco, P | 1 |
| Casarini, DE; Fiorino, P; Irigoyen, MC; Lagranha, CJ; Schaan, BD | 1 |
| Amado, D; Argañaraz, GA; Boim, MA; Canzian, M; Carrete, H; Cavalheiro, EA; Centeno, RS; Costa, LG; Junior, JA; Konno, AC; Mazzacoratti, Mda G; Perosa, SR; Porcionatto, MA; Sakamoto, AC; Santiago, JF; Varella, PP; Vidotti, DB; Yacubian, EM | 1 |
| Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Kim, S; Miura, K; Ohta, K; Omura, T; Wada, T; Yukimura, T | 1 |
| Alcázar, R; Bustos, C; Egido, J; Gómez-Garre, D; González, E; González, S; Palacios, I; Plaza, JJ; Ruíz-Ortega, M | 1 |
| Ageev, FT; Belenkov, IuN; Dzhakhangirov, TSh; Gkhani, P; Lopatin, IuM; Mareev, VIu | 1 |
| Ishikawa, K; Kai, T; Kurooka, A; Shimada, S; Takenaka, T | 1 |
| Cowley, AW; Dickhout, JG; Dumas, P; Greene, AS; Jacob, HJ; Kaldunski, ML; Roman, RJ | 1 |
5 review(s) available for angiotensin ii and Sclerosis
| Article | Year |
|---|---|
[Proteases and antiproteases in the progression of chronic renal insufficiency lesions. The role of the tissue renin-angiotensin system and the renin receptor].
Topics: Angiotensin II; Disease Progression; Endocardium; Endopeptidases; Extracellular Matrix Proteins; Glomerular Mesangium; Humans; Kidney; Kidney Failure, Chronic; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Protease Inhibitors; Receptors, Cell Surface; Renin-Angiotensin System; Sclerosis; Vacuolar Proton-Translocating ATPases | 2002 |
[Vasoactive peptides and the development of renal sclerosis: contribution of transgenes].
Topics: Angiotensin II; Animals; Collagen Type II; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Fibrosis; Genes, Reporter; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Luciferases; MAP Kinase Signaling System; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta; Transgenes | 2002 |
[The concept of nephroprotection: toward preventive and curative therapies for renal sclerosis].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Endothelins; Humans; Ischemia; Kidney; Kidney Failure, Chronic; Kidney Tubules, Proximal; Mice; Models, Animal; Proteinuria; Rats; Sclerosis; Transforming Growth Factor beta | 2002 |
[Molecular bases of diabetic nephropathy].
Topics: Angiotensin II; Cell Proliferation; Diabetic Nephropathies; Endothelium-Dependent Relaxing Factors; Extracellular Matrix; Glomerular Mesangium; Glucose Transporter Type 1; Glycation End Products, Advanced; Humans; Hyperglycemia; Nitric Oxide; Oxidative Stress; Renin-Angiotensin System; Sclerosis; Transforming Growth Factor beta1; Vasoconstrictor Agents | 2007 |
Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; Endothelins; Extracellular Matrix Proteins; Fibronectins; Humans; Kidney; Kidney Diseases; Sclerosis | 1994 |
1 trial(s) available for angiotensin ii and Sclerosis
| Article | Year |
|---|---|
[Comparative study on use of angiotensin-converting enzyme inhibitors and cardiac glycosides in the treatment of cardiac insufficiency].
Topics: Adult; Aged; Angiotensin II; Baroreflex; Captopril; Cardiac Output, Low; Chronic Disease; Digoxin; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Norepinephrine; Sclerosis; Stroke Volume; Time Factors | 1993 |
7 other study(ies) available for angiotensin ii and Sclerosis
| Article | Year |
|---|---|
Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade.
Topics: Albuminuria; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Kidney; Kidney Glomerulus; Male; Podocytes; Rats; Rats, Long-Evans; Remission Induction; Sclerosis; Treatment Outcome | 2010 |
Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma.
Topics: Angiotensin II; Aortic Valve; Aortic Valve Stenosis; Apolipoproteins B; Coronary Artery Disease; Humans; Immunohistochemistry; Lipoproteins, LDL; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Sclerosis | 2002 |
The role of the renin-angiotensin system in cholesterol and puromycin mediated renal injury.
Topics: Angiotensin II; Animals; Cholesterol; Diet; Humans; Kidney Diseases; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Proteinuria; Puromycin Aminonucleoside; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Sclerosis | 2002 |
The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis.
Topics: Adult; Angiotensin II; Cerebral Cortex; Female; Hippocampus; Humans; Male; Middle Aged; NF-kappaB-Inducing Kinase; Protein Serine-Threonine Kinases; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; RNA, Messenger; Sclerosis; Temporal Lobe; Up-Regulation | 2008 |
Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cerebrovascular Disorders; Extracellular Matrix; Gene Expression; Hypertension, Renal; Kidney; Kidney Glomerulus; Male; Phenotype; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Sclerosis; Tetrazoles; Transforming Growth Factor beta | 1994 |
Tissue angiotensin II concentration in the heart and kidneys in transgenic Tsukuba hypertensive mice.
Topics: Angiotensin II; Animals; Blood Pressure; Hypertension; Kidney; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardium; Sclerosis | 1998 |
Brown Norway chromosome 13 confers protection from high salt to consomic Dahl S rat.
Topics: Angiotensin II; Animals; Blood Pressure; Fibrosis; Furosemide; Gene Transfer Techniques; Genetic Therapy; Genotype; Hypertension; Kidney Glomerulus; Kidney Medulla; Kidney Tubules; Necrosis; Norepinephrine; Proteinuria; Rats; Rats, Inbred BN; Rats, Inbred Dahl; Renal Artery; Renin; Sclerosis; Sodium Chloride; Sodium, Dietary; Vascular Resistance | 2001 |